Localized and Disseminated Histiocytic Sarcoma of Dendritic Cell Origin in Dogs

Veterinary Pathology

Volumn 39, Issue 1, 2002, Pages 74-83

  Affolter, V K ^a   Moore, P F ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

CD1; CD11c; dendritic antigen presenting cells; dogs; histiocytic sarcoma; histopathology; ICAM 1; immunohistochermistry; malignant histiocytosis; MHC II

Indexed keywords

DIFFERENTIATION ANTIGEN;

ANIMAL; ANIMAL DISEASE; ARTICLE; BIOPSY; DENDRITIC CELL; DOG; DOG DISEASE; HEMATOPOIETIC STEM CELL; IMMUNOHISTOCHEMISTRY; MALIGNANT HISTIOCYTOSIS; METASTASIS; METHODOLOGY; PATHOLOGY; SARCOMA; SPINAL CORD; SPLEEN;

ANIMALS; ANTIGENS, DIFFERENTIATION; BIOPSY; DENDRITIC CELLS; DOG DISEASES; DOGS; HEMATOPOIETIC STEM CELLS; HISTIOCYTOSIS, MALIGNANT; IMMUNOHISTOCHEMISTRY; NEOPLASM METASTASIS; SARCOMA; SPINAL CORD; SPLEEN;

EID: 0036052342     PISSN: 03009858     EISSN: 15444221     Source Type: Journal    
DOI: 10.1354/vp.39-1-74     Document Type: Article

References (61)

1. Affolter VK, Moore PF: Canine cutaneous and systemic histiocytosis: a reactive histiocytosis of dermal dendritic origin. Am J Dermatopathol 22: 40–48, 2000
2. Austyn JM: Dendritic cells in the spleen and lymph node. In: Dendritic Cells; Biology and Clinical Applications, ed. Lotz MT, Thomson AW, pp. 179–204. Academic Press, San Diego, CA, 1999
3. Broadbent V, Egeler RM, Nesbit ME Jr: Langerhans cell histiocytosis—clinical and epidemiological aspects. Br J Cancer Suppl 23: 11–16, 1994
4. Bucsky P, Egeler RM: Malignant histiocytic disorders in children. Clinical and therapeutic approaches with a nosologic discussion. Hematol Oncol Clin North Am 12: 465–471, 1998
5. Calabi F, Bradbury A: The CD1 system. Tissue Antigens 37: 1–9, 1991
6. Caux C, Dezutter-Dambuyant C, Schmitt D, Banchereau J: GM-CSF and TNF-alpha cooperate in the generation of dendritic Langerhans cells. Nature 360: 258–261, 1992
7. Caux C, Vanbervliet B, Massacrier C, Dezutter-Dambuyant C, de Saint-Vis B, Jacquet C, Yoneda K, Imamura S, Schmitt D, Banchereau J: CD34+ hematopoietic progenitors from human cord blood differentiate along two independent dendritic cell pathways in response to GMCSF+TNF alpha. J Exp Med 184: 695–706, 1996
8. Caux C, Vanbervliet B, Massacrier C, Durand I, Banchereau J: Interleukin-3 cooperates with tumor necrosis factor alpha for the development of human dendritic/Langerhans cells from cord blood CD34+hematopoietic progenitor cells. Blood 87: 2376–2385, 1996
9. Cerio R, Griffiths CE, Cooper KD, Nickoloff BJ, Headington JT: Characterization of factor XIIIa positive dermal dendritic cells in normal and inflamed skin. Br J Dermatol 121: 421–431, 1989
10. Egeler RM, Schmitz L, Sonneveld P, Mannival C, Nesbit ME: Malignant histiocytosis: a reassessment of cases formerly classified as histiocytic neoplasms and review of the literature. Med Pediatr Oncol 25: 1–7, 1995
11. Favara BE, Feller AC, Pauli M, Jaffe ES, Weiss LM, Arico M, Bucsky P, Egeler RM, Elinder G, Gadner H, Gresik M, Henter JI, Imashuku S, Janka-Schaub G, Jaffe R, Ladisch S, Nezelof C, Pritchard J: Contemporary classification of histiocytic disorders. The WHO Committee on Histiocytic/Reticulum Cell Proliferations. Reclassification Working Group of the Histiocyte Society. Med Pediatr Oncol 29: 157–166, 1997
12. Furue M, Nindl M, Kawabe K, Nakamura K, Ishibashi Y, Sagawa K: Epitope mapping of CD1a, CD1b, and CD1c antigens in human skin: differential localization on Langerhans cells, keratinocytes, and basement membrane zone. J Invest Dermatol 99(Suppl): 23–26, 1992
13. Gadner H: The histiocytic syndromes. In: Dermatology in General Medicine, ed. Fitzpatrick TB, Eisen AZ, Wolff K, Freedberg IM, Austen KF, 4th ed., pp. 2003–2010. McGraw-Hill, New York, NY, 1993
14. Gleiser CA, Raulston GL, Jardine JH, Gray KN: Malignant fibrous histiocytoma in dogs and cats. Vet Pathol 16: 199–208, 1979
15. Glick AD, Holscher M, Campbell GR: Canine cutaneous histiocytoma: ultrastructural and cytochemical observations. Vet Pathol 13: 374–380, 1976
16. Gogusev J, Nezelof C: Malignant histiocytosis. Histologic, cytochemical, chromosomal, and molecular data with a nosologic discussion. Hematol Oncol Clin North Am 12: 445–463, 1998
17. Gross TL, Affolter VK. Advances in skin oncology. In: Advances in Veterinary Dermatology.ed. Kwochka KW, Willemse T, von Tscharner C, pp. 382–385. Butterworth-Heinemann, Oxford, UK, 1998
18. Hayden DW, Waters DJ, Burke BA, Manivel JC: Disseminated malignant histiocytosis in a Golden Retriever: clinicopathologic, ultrastructural, and immunohistochemical findings. Vet Pathol 30: 256–264, 1993
19. Hendrick MJ, Brooks JJ, Bruce EH: Six cases of malignant fibrous histiocytoma of the canine spleen. Vet Pathol 29: 351–354, 1992
20. Hsu SM, Ho YS, Hsu PL: Lymphomas of true histiocytic origin. Expression of different phenotypes in so-called true histiocytic lymphoma and malignant histiocytosis. Am J of Pathol 138: 1389–1404, 1991
21. Katenkamp D: Morphology and molecular biology of malignant soft tissue sarcomas. Schweiz Rundsch Med Prax 87: 1043–1049, 1998
22. Kelly DF: Canine cutaneous histiocytoma. A light and electron microscopic study. Pathol Vet 7: 12–27, 1970
23. Kerlin RL, Hendrick MJ: Malignant fibrous histiocytoma and malignant histiocytosis in the dog—convergent or divergent phenotypic differentiation?. Vet Pathol 33: 713–716, 1996
24. Laeng H, Gerber H, Mueller J: Malignant histiocytosis (histiocytic sarcoma). A (the?.) major cause of the ‘midline granuloma syndrome’. Acta Otolaryngol (Stockh) 101: 135–145, 1986
25. Maurer D, Stingle G: Dendritic cells in the context of skin immunity. In: Dendritic Cells; Biology and Clinical Applications, ed. Lotz TM, Thomson AW, pp. 111–122. Academic Press, San Diego, CA, 1999
26. Mays MB, Bergeron JA: Cutaneous histiocytosis in dogs. J Am Vet Med Assoc 188: 377–381, 1986
27. McWilliam AS, Stumbles PA, Holt PG: Dendritic cells in the lung. In: Dendritic Cells; Biology and Clinical Applications, ed. Lotz TM, Thomson AW, pp. 123–140. Academic Press, San Diego, CA, 1999
28. Meister P: Malignant fibrous histiocytoma. History, histology, histogenesis. Pathol Res Pract 183: 1–7, 1988
29. Meunier L, Gonzalez-Ramos A, Cooper KD: Heterogeneous populations of class II MHC+ cells in human dermal cell suspensions. Identification of a small subset responsible for potent dermal antigen-presenting cell activity with features analogous to Langerhans cells. J Immunol 151: 4067–4080, 1993
30. Moore PF: Systemic histiocytosis of Bernese mountain dogs. Vet Pathol 21: 554–563, 1984
31. Moore PF, Affolter VK, Olivry T, Schrenzel MD: The use of immunological reagents in defining the pathogenesis of canine skin diseases involving proliferation of leukocytes. In: Advances in Veterinary Dermatology. eds. Kwochka KW, Willemse T, von Tscharner C, pp. 77–94. Butterworth-Heinemann, Oxford, 1998
32. Moore PF, Rosin A: Malignant histiocytosis of Bernese mountain dogs. Vet Pathol 23: 1–10, 1986
33. Moore PF, Schrenzel MD, Affolter VK, Olivry T, Naydan D: Canine cutaneous histiocytoma is an epidermotropic Langerhans cell histiocytosis that expresses CD1 and specific beta 2-integrin molecules. Am J Pathol 148: 1699–1708, 1996
34. Olweus J, BitMansour A, Warnke R, Thompson PA, Carballido J, Picker LJ, Lund-Johansen F: Dendritic cell ontogeny: a human dendritic cell lineage of myeloid origin. Proc Natl Acad Sci USA 94: 12551–12556, 1997
35. Peaston AE, Munn RJ, Madewell BR: Clinical vignette. A 7-year-old Bernese Mountain Dog with anemia. J Vet Intern Med 7: 101–103, 1993
36. Porcelli SA, Segelke BW, Sugita M, Wilson IA, Brenner MB: The CD1 family of lipid antigen presenting molecules. Immunol Today 19: 362–368, 1998
37. Ramsey IK, McKay JS, Rudorf H, Dobson JM: Malignant histiocytosis in three Bernese Mountain Dogs. Vet Rec 138: 440–444, 1996
38. Roholl PJ, Kleyne J, Pijpers HW, Van Unnik JA: Comparative immunohistochemical investigation of markers for malignant histiocytes. Hum Pathol 16: 763–771, 1985
39. Rosin A, Moore P, Dubielzig R: Malignant histiocytosis in Bernese Mountain Dogs. J Am Vet Med Assoc 188: 1041–1045, 1986
40. Saraya K, Reid CD: Synergistic interaction between ckit ligand (SCF), GM-CSF and TNF promotes optimal dendritic Langerhans cell proliferation from primitive progenitors in human bone marrow. Adv Exp Med Biol 378: 13–16, 1995
41. Scherlie PH Jr, Smedes SL, Feltz T, Dougherty SA, Riis RC: Ocular manifestation of systemic histiocytosis in a dog. J Am Vet Med Assoc 201: 1229–1232, 1992
42. Schmidt D: Monocyte/macrophage system and malignancies. Med Pediatr Oncol 23: 444–451, 1994
43. Schmidt ML, Rutteman GR, van Niel MH, Wolvekamp PT: Clinical and radiographic manifestations of canine malignant histiocytosis. Vet Q 15: 117–120, 1993
44. Schmidt ML, Rutteman G, Wolvekamp P: Canine malignant histiocytosis (MH): clinical and radiographic findings. Tijdschr Diergeneeskd 117(Suppl 1): 43–44, 1992
45. Schmitz L, Favara BE: Nosology and pathology of Langerhans cell histiocytosis. Hematol Oncol Clin North Am 12: 221–246, 1998
46. Scott DW, Angarano DK, SM M.: Systemic histiocytosis in two dogs. Canine Pract 14: 7–12, 1987
47. Scott DW, Miller WH, Griffin CE: Muller & Kirk's Small Animal Dermatology, 6th ed., pp. 1355-1357. WB Saunders, Philadelphia, PA, 1995
48. Shi SR, Chaiwun B, Young L, Cote RJ, Taylor CR: Antigen retrieval technique utilizing citrate buffer or urea solution for immunohistochemical demonstration of androgen receptor in formalin-fixed paraffin sections. J Histochem Cytochem 41: 1599–1604, 1993
49. Shortman K, Caux C: Dendritic cell development: multiple pathways to nature's adjuvants. Stem Cells 15: 409–419, 1997
50. Soloeta R, Yanguas I, Saracibar N, Goday JJ: Multiple clustered histiocytofibroma. Apropos of a case with immunohistochemical study. Ann Dermatol Venereol 121: 482–484, 1994
51. Soria C, Orradre JL, Garcia-Almagro D, Martinez B, Algara P, Piris MA: True histiocytic lymphoma (monocytic sarcoma). Am J Dermatopathol 14: 511–517, 1992
52. Spangler WL, Kass PH: Pathologic and prognostic characteristics of splenomegaly in dogs due to fibrohistiocytic nodules: 98 cases. Vet Pathol 35: 488–498, 1998
53. Stingl G, Bergstresser PR: Dendritic cells: a major story unfolds. Immunol Today 16: 330–333, 1995
54. Strobl H, Bello-Fernandez C, Riedl E, Pickl WF, Majdic O, Lyman SD, Knapp W: flt3 Ligand in cooperation with transforming growth factor-beta1 potentiates in vitro development of Langerhans-type dendritic cells and allows single-cell dendritic cell cluster formation under serumfree conditions. Blood 90: 1425–1434, 1997
55. Strunk D, Rappersberger K, Egger C, Strobl H, Kromer E, Elbe A, Maurer D, Stingl G: Generation of human dendritic cells/Langerhans cells from circulating CD34+hematopoietic progenitor cells. Blood 87: 1292–1302, 1996
56. Thoolen RJ, Vos JH, van der Linde-Sipman JS, de Weger RA, van Unnik JA, Misdorp W, van Dijk JE: Malignant fibrous histiocytomas in dogs and cats: an immunohistochemical study. Res Vet Sci 53: 198–204, 1992
57. Uno Y, Momoi Y, Watari T, Goitsuka R, Tsujimoto H, Shimada T, Ono K, Goto N, Hasegawa A: Malignant histiocytosis with multiple skin lesions in a dog. J Vet Med Sci 55: 1059–1061, 1993
58. Ushigome S, Shimoda T, Nikaido T, Takasaki S: Histopathologic diagnostic and histogenetic problems in malignant soft tissue tumors. Reassessment of malignant fibrous histiocytoma, epithelioid sarcoma, malignant rhabdoid tumor, and neuroectodermal tumor. Acta Pathol Jpn 42: 691–706, 1992
59. Vedel J, Vincendeau P, Bezian JH, Taieb A: Flow cytometry analysis of adhesion molecules on human Langerhans cells. Clin Exp Dermatol 17: 240–245, 1992
60. Wellman ML, Davenport DJ, Morton D, Jacobs RM: Malignant histiocytosis in four dogs. J Am Vet Med Assoc 187: 919–921, 1985
61. Wilson MS, Weiss LM, Gatter KC, Mason DY, Dorfman RF, Warnke RA: Malignant histiocytosis. A reassessment of cases previously reported in 1975 based on paraffin section immunophenotyping studies. Cancer 66: 530–536, 1990